Chondroitinase and growth factors enhance activation and oligodendrocyte differentiation of endogenous neural precursor cells after spinal cord injury.
about
Oligodendrogenesis in the normal and pathological central nervous systemChondroitin sulfate proteoglycans in the nervous system: inhibitors to repairRemyelination Therapy in Multiple SclerosisOligodendrocyte Precursor Cells in Spinal Cord Injury: A Review and UpdateMyelin damage and repair in pathologic CNS: challenges and prospectsThe Potential for iPS-Derived Stem Cells as a Therapeutic Strategy for Spinal Cord Injury: Opportunities and ChallengesThe multifaceted effects of agmatine on functional recovery after spinal cord injury through Modulations of BMP-2/4/7 expressions in neurons and glial cellsInjury to the spinal cord niche alters the engraftment dynamics of human neural stem cellsHuman umbilical cord Wharton's jelly-derived oligodendrocyte precursor-like cells for axon and myelin sheath regeneration.Examination of the combined effects of chondroitinase ABC, growth factors and locomotor training following compressive spinal cord injury on neuroanatomical plasticity and kinematics.The neuron regrowth is associated with the proliferation of neural precursor cells after leukemia inhibitory factor administration following spinal cord injury in mice.Advances in regenerative therapies for spinal cord injury: a biomaterials approach.The axon-glia unit in white matter stroke: mechanisms of damage and recovery.Myelin Proteolipid Protein Complexes with αv Integrin and AMPA Receptors In Vivo and Regulates AMPA-Dependent Oligodendrocyte Progenitor Cell Migration through the Modulation of Cell-Surface GluR2 Expression.Demyelination as a rational therapeutic target for ischemic or traumatic brain injury.The reactions and role of NG2 glia in spinal cord injury.Epidermal growth factor attenuates blood-spinal cord barrier disruption via PI3K/Akt/Rac1 pathway after acute spinal cord injury.Effects of adult neural precursor-derived myelination on axonal function in the perinatal congenitally dysmyelinated brain: optimizing time of intervention, developing accurate prediction models, and enhancing performanceAstrocytic and vascular remodeling in the injured adult rat spinal cord after chondroitinase ABC treatment.Alternatively activated macrophages in spinal cord injury and remission: another mechanism for repair?Multiple sclerosis: does Nogo play a role?Biologic scaffold for CNS repair.Spinal cord injury and the neuron-intrinsic regeneration-associated gene program.From demyelination to remyelination: the road toward therapies for spinal cord injury.Neural stem cell mediated recovery is enhanced by Chondroitinase ABC pretreatment in chronic cervical spinal cord injury.Applications of induced pluripotent stem cell technologies in spinal cord injury.Attempts to Overcome Remyelination Failure: Toward Opening New Therapeutic Avenues for Multiple Sclerosis.The roles of microRNAs in spinal cord injury.Inhibitors of myelination: ECM changes, CSPGs and PTPs.Synergetic use of neural precursor cells and self-assembling peptides in experimental cervical spinal cord injuryEffect of microenvironment modulation on stem cell therapy for spinal cord injury pain.Dysregulation of the neuregulin-1-ErbB network modulates endogenous oligodendrocyte differentiation and preservation after spinal cord injury.Fibroblast growth factors in the management of spinal cord injury.Biomaterial strategies for limiting the impact of secondary events following spinal cord injury.iPSC-derived neural precursor cells: potential for cell transplantation therapy in spinal cord injury.Neuregulin-1 positively modulates glial response and improves neurological recovery following traumatic spinal cord injury.Neuregulin-1 promotes remyelination and fosters a pro-regenerative inflammatory response in focal demyelinating lesions of the spinal cord.Sustained-release of FGF-2 from a hybrid hydrogel of heparin-poloxamer and decellular matrix promotes the neuroprotective effects of proteins after spinal injury.Poly(glycerol sebacate) combined with chondroitinase ABC promotes spinal cord repair in rats.Combination treatment with anti-Nogo-A and chondroitinase ABC is more effective than single treatments at enhancing functional recovery after spinal cord injury.
P2860
Q21129352-2F2C5CCF-88E9-4D37-A6DD-3F3F8926BC13Q21284516-DDC2A62F-E59B-4F3F-8EC5-D2457183FD41Q26772359-1E722F29-2E11-4707-A107-DE28F53DB7E2Q26780518-09FB1A77-A298-4589-BDA9-DA6AC3ED6C9FQ26797407-49978612-8811-4CBE-8111-3AD8BDB92ABCQ26860309-EA650E06-93C4-4173-A49C-92954C7122CFQ27320717-2E991804-6E64-450B-86E9-F024A1AD15EAQ33730177-0F60B928-D73A-4EB3-B797-ADDBC16DFA2DQ34094606-42F039C3-005B-4C8A-93E2-E6E8275F7120Q34414830-738C1E1E-9085-49B9-9942-0773C12894C9Q34777472-9635E445-6789-48FB-AD46-630F409A3DCFQ35746310-52BA2BD6-169B-4937-8F52-013540F0301BQ35984483-1F55B25A-EC32-4927-95A2-114C82CA1A79Q35995980-C938584C-E148-4F37-93E8-240E053865B7Q36090107-CB88AF0C-DB41-42EB-88FE-84224EA584A6Q36520580-2CA6E4F1-D5FA-4107-B5A8-EFEE03A4758FQ36942359-BB88AE4E-3E72-4050-A91B-6432DF925CC7Q37043442-03EC36C2-E36D-4AD0-AE78-84D6820BFD46Q37718952-9E792733-B242-4D14-B921-2E79273BDD54Q38074291-73612693-F744-4C69-B6A2-999ECBB8E0FFQ38082999-AE730843-E949-45E3-8A1F-314A08AA6F89Q38220716-61A5F2E5-DD21-4D83-BFFD-971445CFDD30Q38255644-0EBD3E3B-8243-4202-BF39-7D567BAAF9A4Q38366783-977EB6CE-D4D5-4069-8694-FC1DB9A0F21AQ38644409-578C3B7A-F92A-4A20-B452-7F7511281992Q39136445-FE89B89C-650D-4519-87E4-9545BB9AE146Q39146141-7731F2E6-B04E-409A-9B70-F3D9B9014258Q39258451-ED8530F4-5681-49AE-8466-D53347A3B95CQ40804371-A4DAF815-2CB7-469D-A783-94CB60ECD1FFQ42063268-F342FEC3-C2CD-42BA-8CAB-CB0A51105A9DQ42099065-8E44DB85-95E3-45AE-891D-5070BC799247Q45139454-1100D456-27BA-4027-BE33-C6113F96FC49Q47147917-DAB7FF38-DFF8-4A6C-859E-3495DC42C5DEQ47332307-6F1A0F82-5CDC-4973-B33F-19399E5FFDB7Q47906823-E71DC3AD-A2B0-485E-8A9E-B3605640CE21Q48215785-2EFD52A1-03C2-403D-BDA3-90283D103DA6Q48284501-743ACF00-8611-4062-9490-B1B3661DAC15Q49280261-00525F1F-1C60-4838-BAFB-7B47D2F087F7Q50121957-4AB28A81-B6B8-4571-B4CF-DC4E979F51E1Q50888613-C4716DF7-A42E-490D-B1D5-B3334351EE50
P2860
Chondroitinase and growth factors enhance activation and oligodendrocyte differentiation of endogenous neural precursor cells after spinal cord injury.
description
2012 nî lūn-bûn
@nan
2012 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Chondroitinase and growth fact ...... ells after spinal cord injury.
@ast
Chondroitinase and growth fact ...... ells after spinal cord injury.
@en
Chondroitinase and growth fact ...... ells after spinal cord injury.
@nl
type
label
Chondroitinase and growth fact ...... ells after spinal cord injury.
@ast
Chondroitinase and growth fact ...... ells after spinal cord injury.
@en
Chondroitinase and growth fact ...... ells after spinal cord injury.
@nl
prefLabel
Chondroitinase and growth fact ...... ells after spinal cord injury.
@ast
Chondroitinase and growth fact ...... ells after spinal cord injury.
@en
Chondroitinase and growth fact ...... ells after spinal cord injury.
@nl
P2860
P1433
P1476
Chondroitinase and growth fact ...... ells after spinal cord injury.
@en
P2093
Desiree Schut
P2860
P304
P356
10.1371/JOURNAL.PONE.0037589
P407
P577
2012-05-22T00:00:00Z